ClinicalTrials.gov Modernization Public Meeting

Join us virtually on April 25 at 12:30 p.m. Want to learn more about the upcoming changes to the ClinicalTrials.gov website and the new Protocol Registration and Results System (PRS)? We’re hosting a virtual public meeting on Tuesday, April 25 from 12:30 p.m. to 3 p.m. ET to provide a detailed look at the current beta … Continue reading ClinicalTrials.gov Modernization Public Meeting

Using NCBI resources to research, detect, and treat genetic phenotypes

Clinical Genetics Information at Your Fingertips NCBI offers a portfolio of medical genetics resources to help you research, diagnose, and treat diseases and conditions. You can easily access our data and tools through the Medical Genetics and Human Variation page of the NCBI website. We also encourage you to join our community of thousands of … Continue reading Using NCBI resources to research, detect, and treat genetic phenotypes

The post Using NCBI resources to research, detect, and treat genetic phenotypes appeared first on NCBI Insights.

ClinicalTrials.gov updates the PRS Guided Tutorials, step-by-step instructions for data providers

The PRS Guided Tutorials provide step-by-step instructions to help data providers submit information to ClinicalTrials.gov and aims to reduce the number of quality-control reviews needed. The ClinicalTrials.gov team has updated the PRS Guided Tutorials to make them more useful in response to user feedback obtained through focus groups and survey responses over the past year. … Continue reading ClinicalTrials.gov updates the PRS Guided Tutorials, step-by-step instructions for data providers

May 2 webinar: Using NCBI’s MedGen in Clinical Practice

Join us next Wednesday, May 2, 2018, 12:00 PM – 12:30 PM EDT for a webinar on MedGen, NCBI’s portal to clinical genetics. We’ll show you how to find information in MedGen on genetic phenotypes, clinical features of disorders, and … Continue reading

Adventures in Stem Cell Land

Two weeks ago a neurologist asked me to blog about a US-based company that is offering stem cell treatments, because it had raised hopes among some of his patients. Intrigued because I cover  “stem cell tourism” in my bioethics class and … Continue reading »

The post Adventures in Stem Cell Land appeared first on PLOS Blogs Network.